April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Distribution of Gold Nanorods Monitored With Spectral-Domain Optical Coherence Tomography (SD-OCT) After Intravitreal Injection
Author Affiliations & Notes
  • M. L. Gabriele
    Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, Pennsylvania
    UPMC Eye Center, Eye & Ear Institute, Ophthalmology and Visual Science Research Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
  • K. C. McKenna
    UPMC Eye Center, Eye & Ear Institute, Ophthalmology and Visual Science Research Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
  • J. S. Schuman
    Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, Pennsylvania
    UPMC Eye Center, Eye & Ear Institute, Ophthalmology and Visual Science Research Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
  • H. Ishikawa
    Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, Pennsylvania
    UPMC Eye Center, Eye & Ear Institute, Ophthalmology and Visual Science Research Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
  • J. Franks
    Center for Biologic Imaging, University of Pittsburgh, Pittsburgh, Pennsylvania
  • M. Sun
    Center for Biologic Imaging, University of Pittsburgh, Pittsburgh, Pennsylvania
  • W. Halfter
    Neurobiology, University of Pittsburgh, Pittsburgh, Pennsylvania
  • L. Kagemann
    Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, Pennsylvania
    UPMC Eye Center, Eye & Ear Institute, Ophthalmology and Visual Science Research Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
  • G. Wollstein
    UPMC Eye Center, Eye & Ear Institute, Ophthalmology and Visual Science Research Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
  • Footnotes
    Commercial Relationships  M.L. Gabriele, None; K.C. McKenna, None; J.S. Schuman, Bioptigen, P; Carl Zeiss Meditec, P; Carl Zeiss Meditec, R; Heidelberg Engineering, R; Pfizer, R; H. Ishikawa, Bioptigen, P; J. Franks, None; M. Sun, None; W. Halfter, None; L. Kagemann, None; G. Wollstein, Bioptigen, P; Carl Zeiss Meditec, F; Optovue, F.
  • Footnotes
    Support  NIH R21-EY19092; NIH R01-EY013178, P30-EY008098; Eye and Ear Foundation (Pittsburgh, PA); Research to Prevent Blindness
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 420. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. L. Gabriele, K. C. McKenna, J. S. Schuman, H. Ishikawa, J. Franks, M. Sun, W. Halfter, L. Kagemann, G. Wollstein; Distribution of Gold Nanorods Monitored With Spectral-Domain Optical Coherence Tomography (SD-OCT) After Intravitreal Injection. Invest. Ophthalmol. Vis. Sci. 2010;51(13):420.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

Gold nanorods (GNRs) have the potential to be useful for contrast enhancement within optical coherence tomography images. However, the distribution of GNRs in the eye after intravitreal injection has not been documented. The goal of this study was to monitor the location of GNRs using SD-OCT and confirm the location with transmission electron microscopy (TEM).

 
Methods:
 

GNRs were prepared using a well established seed-mediated, surfactant directed synthesis. An aspect ratio of ~4.5 was chosen such that the surface plasmon resonant response matched the center wavelength used in our SD-OCT system (spr = 840 nm). An intravitreal injection of 2 µl of the GNR solution was administered in one eye of eight healthy adult male C57Bl/6 mice; a sham intravitreal injection of 2 µl of phosphate buffered saline (PBS) was administered to four additional mice. Raster 3D SD-OCT images of the retina, lens and vitreous were acquired before and after injection using identical scanning protocols (1.5x1.5x2 mm scan, 250x250x1024 pixels; Bioptigen, Inc, Durham, NC). Six mice (2 sham, 4 GNR) were imaged for 8 days following injection and then sacrificed. The remaining mice were followed for 30 days. TEM was performed on the retinas of six mice and lenses of three mice.

 
Results:
 

An increase in intensity was seen in the vitreous and posterior lens in eyes injected with GNRs, and this was not observed in the eyes that received a sham injection (Figure, a). GNRs were seen by TEM in the vitreous, decorating the hyaloid canal, adherent to the lens, within the lens and in microglia within the retina (Figure, b).

 
Conclusions:
 

GNRs injected into the vitreous stay in the vitreous for at least 30 days after injection, but are also present in the lens and retina. A change in backscattered intensity could be detected within SD-OCT images while the GNRs were present.  

 
Keywords: imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • vitreous • microscopy: electron microscopy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×